Table 2.
Efficacy endpoints | 1st line (n = 12) | 2nd line (n = 20) | Overall (n = 32) | |||
---|---|---|---|---|---|---|
No. | (%) | No. | (%) | No. | (%) | |
Complete response | 2 | (16.7) | 1 | (5.0) | 3 | (9.4) |
Partial response | 7 | (58.3) | 8 | (40.0) | 15 | (46.9) |
Stable disease | 0 | (0.0) | 6 | (30.0) | 6 | (18.7) |
Progressive disease | 3 | (25.0) | 5 | (25.0) | 8 | (25.0) |
Overall response rate | 9 | (75.0) | 9 | (45.0) | 18 | (56.3)* |
*(95%Confidence Interval; 39.0-73.4)